Costs Quote by J. D. Vance

The higher cost of getting a generic drug approved by regulators means that many old medicines don't face competitors. It's only after substantial price…

— Scott Gottlieb

Increasing patient access to more affordable, FDA-approved generic and biosimilar medicines is a proven and tested solution to lowering prescription drug costs.

— Chris Sununu

One dirty tactic big pharmaceutical companies use is keeping drug prices artificially high through anti-competitive conduct, such as paying competitors millions of dollars to…

— Mike Braun

The key to the generic-drug economic model is to keep entry prices low enough to attract multiple competitors.

— Scott Gottlieb

One of the biggest factors fueling the angst over drug prices in the U.S. is that some older medicines that should be sold cheaply…

— Scott Gottlieb

“The average American is unaware of this system—the patenting of drugs from nature, the renewal of patents based on insignificant changes, the aggressive marketing…

— Robert B. Reich

With the Health Impact Fund, the innovation is paid for separately, through publicly funded health impact rewards, and the product is sold at the…

— Thomas Pogge

The value that the generic drug industry brings to the U.S. healthcare system is indisputable.

— Heather Bresch

So here's the situation confronting the drug firms: The drugs cost more to make, but they can't charge more for them. What do they…

— Donald Kennedy

It's crucial to keep in mind that the hundreds of millions of dollars now spent on prescription drug advertisements are ultimately paid for by…

— Michael K. Simpson

“Generics were not created to be a differential advantage against other retailers but to help the retailer control the manufacturer, and they became an…

— Greg Thain

Private companies mostly manufacture medications that resemble what we've already got. They get it patented and, with a hefty dose of marketing, a legion…

— Rutger Bregman